Journal profile · ENGINEERING, BIOMEDICAL
Progress in Biomedical Engineering
ISSN 2516-1091 · Institute of Physics Publishing
Progress in Biomedical Engineering: CAS Zone 3 · Medicine (2025 upgraded edition); hybrid open access; APC about USD 4,680; median 175 days to acceptance (88 articles, last 24 months); 45 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Progress in Biomedical Engineering is published by Institute of Physics Publishing and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are 3D Printing in Biomedical Research, Neuroscience and Neural Engineering and Radiomics and Machine Learning in Medical Imaging, together about 26.9% of its articles. Its main subfields are Biomedical Engineering. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): ENGINEERING, BIOMEDICAL
Main research topics OpenAlex counts of recent articles; shares are approximate
- 3D Printing in Biomedical ResearchEngineering12.8%
- Neuroscience and Neural EngineeringNeuroscience8.1%
- Radiomics and Machine Learning in Medical ImagingMedicine6%
- Muscle activation and electromyography studiesEngineering5.6%
- EEG and Brain-Computer InterfacesNeuroscience4.7%
- Stroke Rehabilitation and RecoveryMedicine4.3%
- Electrospun Nanofibers in Biomedical ApplicationsMaterials Science4.3%
- Soft Robotics and ApplicationsEngineering3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Engineering, Biomedical | Zone 3 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Engineering, Biomedical | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 11.5LetPub ·
- SJR 2026-06
- 1.32LetPub ·
- SNIP 2026-06
- 1.94LetPub ·
- h-index
- 32OpenAlex ·
- i10-index
- 76OpenAlex ·
- 2-year mean citedness
- 3.8OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 70.83%LetPub ·
Volume
- Articles per year
- 40LetPub ·
Articles by year OpenAlex count · 301 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 41 | 39 | 31 |
| 2025 | 45 | 33 | 165 |
| 2024 | 21 | 13 | 211 |
| 2023 | 22 | 22 | 611 |
| 2022 | 18 | 18 | 579 |
| 2021 | 26 | 25 | 873 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
175 daysMedian, submission to acceptance · P25–P75 142 days – 227 days
- Acceptance to online
- median 17 days (88 articles)
- Submission to online
- median 200 days
- Sample
- 88 articles with submission and acceptance dates (96 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,680 / EUR 3,940 / GBP 3,425 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Institute of Physics Publishing
- ISSN
- 2516-1091
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Progress in Biomedical Engineering
What CAS zone is Progress in Biomedical Engineering in?
In the 2025 upgraded edition of the CAS Journal Ranking, Progress in Biomedical Engineering is in Zone 3 of Medicine, and in Zone 3 of the minor category Engineering, Biomedical. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Progress in Biomedical Engineering?
Based on the dates recorded on 88 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 175 days (interquartile range 142–227 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Progress in Biomedical Engineering?
According to LetPub and DOAJ records, Progress in Biomedical Engineering is indexed in ESCI and Scopus.
Is Progress in Biomedical Engineering open access, and what is the APC?
Progress in Biomedical Engineering is a hybrid journal. For open-access publication: APC about USD 4,680.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .